This method presents a robust gene editing approach to restore the dystrophin gene that can be extended to address additional patient deletions common in DMD and serves as a blueprint for correcting the genetic basis of other monogenic hereditary disorders. Here, DMD is linked to Duchenne muscular dystrophy.